Personalis Cost of Goods Sold 2018-2025 | PSNL
Personalis cost of goods sold from 2018 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Personalis Annual Cost of Goods Sold
(Millions of US $) |
| 2024 |
$58 |
| 2023 |
$55 |
| 2022 |
$52 |
| 2021 |
$54 |
| 2020 |
$59 |
| 2019 |
$43 |
| 2018 |
$26 |
| 2017 |
$12 |
Personalis Quarterly Cost of Goods Sold
(Millions of US $) |
| 2025-03-31 |
$13 |
| 2024-12-31 |
$12 |
| 2024-09-30 |
$17 |
| 2024-06-30 |
$15 |
| 2024-03-31 |
$14 |
| 2023-12-31 |
$14 |
| 2023-09-30 |
$15 |
| 2023-06-30 |
$12 |
| 2023-03-31 |
$14 |
| 2022-12-31 |
$14 |
| 2022-09-30 |
$12 |
| 2022-06-30 |
$14 |
| 2022-03-31 |
$11 |
| 2021-12-31 |
$13 |
| 2021-09-30 |
$14 |
| 2021-06-30 |
$14 |
| 2021-03-31 |
$13 |
| 2020-12-31 |
$14 |
| 2020-09-30 |
$14 |
| 2020-06-30 |
$15 |
| 2020-03-31 |
$15 |
| 2019-12-31 |
$12 |
| 2019-09-30 |
$12 |
| 2019-06-30 |
$10 |
| 2019-03-31 |
$10 |
| 2018-12-31 |
|
| 2018-09-30 |
$7 |
| 2018-06-30 |
$6 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.417B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
